$BOLD Audentes Therapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Audentes Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Audentes Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Audentes Therapeutics, Inc. for free.

CIK Number: 0001628738
IRS Number: 461606174
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: BOLD
Company Address: 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO 94108
Phone number: 415-638-6556

Audentes Therapeutics, Inc. is a biotechnology company, which engages on development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. Its products include AT001 for the treatment of X-Linked Myotubular Myopathy, AT002 for the treatment of Pompe disease, and AT003 for the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA.

Market Capitalization: $337.82M
Prev close: $15.83
Average Daily Volume: 57,173
Days Low: $15.30
Year Low: $13.06
Year High: $20.74

Audentes Therapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Conner Edward R.SVP, Chief Medical Officer30,000474,900shares bought: 30,000 / shares sold: 0 BUYJul 17 20194 days ago
Holles Natalie C.President and COO55,714881,953shares bought: 56,723 / shares sold: -2,018 STRONG BUYJun 07 20191 month ago
LANGE LOUIS GDirector290,0014,590,716shares bought: 24,633 / shares sold: -307,558 STRONG SELLJun 26 201925 days ago
Patterson Matthew RChief Executive Officer115,3681,826,275shares bought: 285,700 / shares sold: -203,664 BUYJun 07 20191 month ago
PRASAD SUYASHSenior VP & Chief Med Officer17,479276,693shares bought: 84,236 / shares sold: -67,514 BUYJun 07 20191 month ago
Soloway Thomas PExecutive Vice President, CFO22,324353,389shares bought: 23,333 / shares sold: -2,018 BUYJun 07 20191 month ago

View all Audentes Therapeutics, Inc. insiders.

Audentes Therapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 17 2019BOLDAudentes Therapeut ...Conner Edward R.SVP, Chief Medical ...Option ExerciseA36.0890,0003,247,20090,000
Jul 17 2019BOLDAudentes Therapeut ...Conner Edward R.SVP, Chief Medical ...GrantA0.0030,000030,0000 to 30 K
Jun 26 2019BOLDAudentes Therapeut ...LANGE LOUIS GDirectorSellS39.462007,89215,67815.9 K to 15.7 K (-1.26 %)
Jun 26 2019BOLDAudentes Therapeut ...LANGE LOUIS GDirectorSellS37.8980030,30915,87816.7 K to 15.9 K (-4.80 %)
Jun 26 2019BOLDAudentes Therapeut ...LANGE LOUIS GDirectorSellS40.0060023,999285,799286.4 K to 285.8 K (-0.21 %)
Jun 26 2019BOLDAudentes Therapeut ...LANGE LOUIS GDirectorSellS38.153,602137,409286,399290 K to 286.4 K (-1.24 %)
Jun 26 2019BOLDAudentes Therapeut ...LANGE LOUIS GDirectorSellS37.6015,798594,005290,001305.8 K to 290 K (-5.17 %)
Jun 07 2019BOLDAudentes Therapeut ...PRASAD SUYASHSenior VP & Chief M ...Payment of ExerciseF37.3175728,24417,47918.2 K to 17.5 K (-4.15 %)
Jun 07 2019BOLDAudentes Therapeut ...Patterson Matthew RChief Executive Off ...Payment of ExerciseF37.313,332124,317115,368118.7 K to 115.4 K (-2.81 %)
Jun 07 2019BOLDAudentes Therapeut ...Holles Natalie C.President and COOPayment of ExerciseF37.311,00937,64655,71456.7 K to 55.7 K (-1.78 %)
Jun 07 2019BOLDAudentes Therapeut ...PRASAD SUYASHSenior VP & Chief M ...Payment of ExerciseF37.3175728,24417,47918.2 K to 17.5 K (-4.15 %)
Jun 07 2019BOLDAudentes Therapeut ...Patterson Matthew RChief Executive Off ...Payment of ExerciseF37.313,332124,317115,368118.7 K to 115.4 K (-2.81 %)
Jun 07 2019BOLDAudentes Therapeut ...Soloway Thomas PExecutive Vice Pres ...Payment of ExerciseF37.311,00937,64622,32423.3 K to 22.3 K (-4.32 %)
Jun 07 2019BOLDAudentes Therapeut ...Holles Natalie C.President and COOPayment of ExerciseF37.311,00937,64655,71456.7 K to 55.7 K (-1.78 %)
Jun 07 2019BOLDAudentes Therapeut ...Soloway Thomas PExecutive Vice Pres ...Payment of ExerciseF37.311,00937,64622,32423.3 K to 22.3 K (-4.32 %)

View all Audentes Therapeutics, Inc. insider transactions.